CWRU‘s pain neurostimulation spinout has secured series BB funding ahead of a 180-patient trial.

Boston Scientific-backed pain cessation implant developer Neuros has secured $38m in a round co-led by Sectoral Asset Management and Amzak Health.

The talent management and multi-media production company has enlisted MRC as its first disclosed corporate investor as it looks to expand into new business areas.

The Fosun and TAL Education-backed parenting app developer has secured $38.6m from two China-based venture capital firms.

Existing investor Pasteur Mutualité came back for a round that will precede a trial of Volta's software, which helps in the treatment of cardiac arrythmias.

EV Growth took part in a $30m round for the robo-adviser developer, which had been acquired by Stockbit in early 2019.

Kirin has become the first known corporate investor to take a small stake in the beer brand, in a deal valuing it a bit below $300m.

Hanwha Systems has agreed to provide $30m in funding for the satellite technology provider, whose existing investors include Liberty Global and Intelsat.

The service robot technology developer has raised a fresh funding round sized at hundreds of millions of yuan, which came nine months after its $28.6m series B round.

Legend Star and CMB International are among the participants in the cancer drug developer’s latest round, which was led by Tsing Song Capital.